GlassScriptPhysician profile
George Green
NPI 1477008274
$5,575.09
in general payments reported to CMS, 2019-2025
18 companies · $1,334 in 2025
The $1,334 reported for 2025 was more than what 94% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $642 · 2020: $333 · 2021: $537 · 2022: $224 · 2023: $965 · 2024: $1,541 · 2025: $1,334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,840.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,839.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,173.04 | 2020-2025 | Total30, Precision 1, Dailies Total1 |
| Coopervision INC. | $665.69 | 2019-2025 | Misight Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Bausch & Lomb Americas INC. | $657.23 | 2022-2024 | Infuse, Miebo, Xiidra |
| Johnson & Johnson Vision Care, INC. | $453.39 | 2020-2025 | Acuvue |
| Abbvie INC. | $402.66 | 2022-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $380.60 | 2019-2021 | |
| Amgen INC. | $279.67 | 2024-2025 | Tepezza |
| Dompe US, INC. | $243.99 | 2024-2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $237.52 | 2023-2024 | Cequa |
| Johnson & Johnson Surgical Vision, INC. | $174.91 | 2019 | |
| Biotissue Holdings INC. | $174.83 | 2022-2024 | |
| Glaukos Corporation | $166.36 | 2019-2025 | Photrexa Viscous and Photrexa |
| Sight Sciences, INC. | $148.64 | 2024 | Tearcare System |
| Harrow Eye, LLC | $121.93 | 2025 | Vevye |
| Astellas Pharma US INC | $121.85 | 2023 | Izervay |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optovue, INC. | $87.03 | 2019 | |
| Allergan, INC. | $60.56 | 2022 | |
| Abb Con-Cise Optical Group LLC | $25.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.